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Summary We examined whether Saikokeishito extract (TJ-10), a traditional Japanese herbal
medicine, exerts a therapeutic effect on α-naphthylisothiocyanate (ANIT)-induced liver injury
in rats through attenuation of enhanced neutrophil infiltration and oxidative stress in the liver
tissue. In rats treated once with ANIT (75 mg/kg, i.p.), liver injury with cholestasis occurred
24 h after treatment and progressed at 48 h. When ANIT-treated rats orally received TJ-10
(0.26, 1.3 or 2.6 g/kg) at 24 h after the treatment, progressive liver injury with cholestasis was
significantly attenuated at 48 h after the treatment at the dose of 1.3 or 2.6 g/kg. At 24 h after
ANIT treatment, increases in hepatic lipid peroxide and reduced glutathione contents and
myeloperoxidase activity occurred with decreases in hepatic superoxide dismutase and
glutathione reductase activities. At 48 h after ANIT treatment, these changes except for reduced
glutathione were enhanced with decreases in catalase, Se-glutathione peroxidase, and glucose-
6-phosphate dehydrogenase activities. TJ-10 (1.3 or 2.6 g/kg) post-administered to ANIT-treated
rats attenuated these changes found at 48 h after the treatment significantly. These results
indicate that TJ-10 exerts a therapeutic effect on ANIT-induced liver injury in rats possibly
through attenuation of enhanced neutrophil infiltration and oxidative stress in the liver tissue.
Key Words: α-naphthylisothiocyanate, liver injury (rat), Saikokeishito extract (TJ-10), 
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Introduction
The hepatotoxicity of α-naphthylisothiocyanate (ANIT) in
experimental animals is thought to be useful for studying the
mechanisms of drug-induced cholestasis, because cholestasis
and hepatic damage resulting from the administration of
certain drugs (e.g., erythromycin estolate, chlorpromazine,
and others) to humans are mimicked by ANIT administration
to rats [1]. The mechanisms of ANIT-induced liver injury
have been proposed but have not been entirely clarified [2].
It has been suggested the contribution of neutrophils, i.e.,
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polymorphonuclear leukocytes, to the development of ANIT-
induced liver injury in rats through a mechanism independent
of the production of reactive oxygen species (ROS) [3]. It
has been shown in an in vitro experiment that ANIT causes
neutrophils to release toxic proteases, which cause hepato-
cellular damage, and that ANIT causes bile duct epithelial
cells to release a factor(s) that attracts neutrophils and
stimulates them to injure hepatocytes [4, 5]. In contrast, we
have suggested that lipid peroxidation induced by ROS
derived from infiltrated neutrophils might be closely associ-
ated with the formation and progression of ANIT-induced
acute liver injury in rats [6]. Our previous reports showed
that, in the liver of rats treated once with ANIT, the activities
of superoxide dismutase (SOD), an enzyme to scavenge
superoxide radical (O2˙−), and glutathione reductase (GSSG-
R), an enzyme to regenerate reduced glutathione (GSH) from
oxidized glutathione (GSSG) using NADPH, decreased with
the formation and progression of liver injury [7–9]. In
addition, the hepatic activities of catalase, an enzyme to
decompose hydrogen peroxide (H2O2), and Se-glutathione
peroxidase (Se-GSH-Px), an enzyme to metabolize H2O2 and
lipid hydroperoxides using GSH as a co-substrate, transiently
increased before the appearance of ANIT-induced liver
injury, although hepatic catalase and Se-GSHpx activities
decreased at a progressed stage of the injury [7–9]. In
contrast, hepatic GSH content remained increased during
the formation and progression of ANIT-induced liver injury
[7–9].
Saikokeshito (Chai-Hu-Gui-Zhi-Tang) is a traditional
Japanese herbal medicine, i.e., Kampo medicine, which is
composed of 9 herbs such as Bupleuri Radix,  Pinelliae
Tuber, Scutellariae Radix, Glycyrrhizae Radix, Cinnamomi
Cortex,  Paeonia Radix,  Ziyphi Fructus,  Ginseng Radix,
and Zingibers Rhizoma. This Kampo medicine is clinically
used for treatments of duodenal ulcers, pancreatitis, and
chronic liver diseases in Japan. Feeding a diet containing
a spray-dried material of Saikokeishito extract (Tsumura
TJ-10) is known to protect against liver injury induced by
D-galactosamine-induced liver injury with reduction of
increased hepatic lipid peroxide (LPO) level in mice [10]
and gut ischemia/reperfusion-induced liver injury in rats
through nitric oxide (NO)-mediated inhibition of neutrophil
infiltration into the liver tissue [11]. Our previous report has
shown that a single oral administration of TJ-10 to ANIT-
treated rats prevents the progression of liver injury with
cholestasis and attenuates an enhanced increase in serum
LPO level [12]. TJ-10 is known to exert an antioxidant
action by inhibiting lipid peroxidation in vitro [13]. TJ-10 is
also known to possess an activity to scavenge ROS such as
O2˙− and hydroxyl radical (˙OH) in vitro [14]. However, it is
still unclear whether TJ-10 exerts a therapeutic effect on
ANIT-induced liver injury in rats through attenuation of
enhanced neutrophil infiltration and oxidative stress associated
with disrupted antioxidant defense systems in the liver.
In order to clarify the mechanism for the therapeutic effect
of TJ-10 on ANIT-induced liver injury with cholestasis,
we, therefore, examined whether orally administered TJ-10
attenuates enhanced hepatic neutrophil infiltration and oxi-
dative stress associated with disrupted antioxidant defense
systems at a progressed stage of liver injury in rats treated
once with ANIT. Namely, we examined the effect of orally
administered TJ-10 on liver injury progression and changes
in hepatic LPO and GSH contents and the hepatic activity
of myeloperoxidase (MPO), an index of tissue neutrophil
infiltration [15–17], with liver injury progression in rats
treated once with ANIT. We also examined the effect of TJ-
10 administration on the hepatic activities of antioxidant
enzymes such as SOD, catalase, Se-GSHpx, GSSG-R, and
glucose-6-phosphate dehydrogenase (G-6-PDH), an enzyme
to produce NAPDH using glucose-6-phospahte, with liver
injury progression in ANIT-treated rats.
Materials and Methods
Chemicals
TJ-10 is a spray-dried material of Saikokeishito extract.
This herbal medicine was kindly provided by Tsumura &
Co. (Tokyo, Japan). TJ-10 was prepared from a boiled water
extract of the following herbs: 7.0 g Bupleuri Radix
(Bupleuri falcatum Linne), 4.0 g Pinelliae Tuber (Pinellia
ternate Breitenbach), 2.0 g Scutellariae Radix (Scutellaria
baicalensis Georgi), 2.0 g Glycyrrhizae Radix (Glycyrrhiza
glabra Linne), 2.0 g Cinnamomi Cortex ( Cinnamomum
cassia Blume), 2.0 g Paeonia Radix ( Paeonia albiflora
Pallas) 2.0 g Zizyphi Fructus (Zizyphus vulgaris Lamark),
2.0 g  Ginseng Radix ( Panax ginseng C.A. Meyer), and
1.0 Zingiberis Rhizoma (Zingiber officinale Roscoe). The
extraction percentage of the prepared TJ-10 was 18.2%.
The main components present in the TJ-10 preparation
were confirmed by analysis using high-performance liquid
chromatography (HPLC) with spectrophotometric detection
as follows: TJ-10 preparation (1.0 g) was extracted with
methanol (20 ml) under ultrasonication for 30 min. The
solution was filtrated and then submitted for HPLC analysis.
HPLC equipment was controlled with a HPLC pump (LC-
10AD, Shimadzu, Kyoto, Japan) using a TSK-GEL 80TS
column (4.6 Ø × 250 cm) (TOSOH, Tokyo, Japan), eluting
with solvents (A) 0.05 mM acetic acid-ammonium acetate
buffer (pH 3.6) and (B) acetonitrile. A linear gradient of
90% A and 10% B changing over 60 min to 0% A and 100%
B was used. The flow rate was 1.0 ml/min. The eluate from
the column was monitored in a 200 and 400 nm wavelength
range, and the three-dimensional data were processed by a
diode array detector, SPD-M10A (Shimadzu, Kyoto, Japan).
The three-dimensional HPLC chart of the methanol solution
of TJ-10 preparation is shown in Fig. 1. This TJ-10TJ-10 and ANIT-Induced Liver Injury
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contained saikosaponin b1, saikosaponin b2 (derived from
Bupleuri Radix), baicalin, oroxykin A, oroxykin A 7-O-
glucuronide, wogonin, wogonin 7-O-glucuronide, baicalein,
baicalein 7-O-glucoside, skullapflavone II (from Scutellariae
Radix), liquirtin, liquiritin apioside, liquiritigenin, isoliquiritin,
isoliqiritin apioside, isoliquiritigenin, glycyrrhizin, formo-
montetin, glycycoumarin (derived from Glycyrrhizae Radix),
cinnamic acid, cinnamaldehyde (from Cinnamomi Cortex),
oxypaeoniflorin, albiflorin, and paeoniflorin (from Paeonia
Radix). ANIT, 3,3',5,5'-tetramethylbenzidne, and xanthine
were purchased from Sigma Chemical Co. (St. Louis, MO);
milk xanthine oxidase and SOD purified from bovine erythro-
cytes were from Roche-Diagnostics (Tokyo, Japan): N,N-
dimethylformamide, ethylenediaminetetraacetic acid (EDTA),
NADPH, NADP+, GSH, GSSG, 2-thiobarbituric acid, yeast
GSSG-R, and other chemicals were from Wako Pure
Chemical Industry Ltd. (Osaka, Japan). These reagents were
used without further purification.
Animals
Male Wistar rats aged 6 weeks were purchased from
Nippon SLC Co. (Hamamatsu, Japan). The animals were
maintained under a daily controlled 12 h-light, 12 h-dark
lighting cycle at 23ºC and 50% humidity with free access to
rat chow (Oriental MF, Oriental Yeast Co., Tokyo, Japan)
and water for one week prior to the experiments. All animals
received humane care in compliance with the guidelines of
the Management of Laboratory Animals in Fujita Health
University, Japan.
ANIT and TJ-10 treatments and sample collection
Seven-week-old rats fasted for 15 h received an intra-
peritoneal (i.p.) injection of ANIT, dissolved in olive oil, at
a dose of 75 mg/kg body weight (BW), i.e., 1 ml of an ANIT
solution in olive oil (75 mg/ml) per 100 g BW, in order
to induce liver injury, as described previously [7–9]. The
control rats were age-matched and also fasted for 15 h. They
received an i.p. injection of the same volume of olive oil. At
24 h after the initial ANIT or vehicle injection, TJ-10 (0.26,
1.3 or 2.6 g/kg BW), suspended in 1 ml of distilled water,
was orally administered to rats with and without ANIT
injection. Rats without TJ-10 administration received a
single oral administration of the same volume of distilled
water at the same time point. Each rat fasted for 15 h was
sacrificed under ether anesthesia at 24 or 48 h after the initial
ANIT or vehicle injection at which time blood was collected
Fig. 1. Three-dimensional HPLC profile of main components in the methanol extract of TJ-10.Y. Ohta et al.
J. Clin. Biochem. Nutr.
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form the inferior vena cava. The collected blood was
separated into serum by centrifugation. Immediately after
sacrifice, the livers were well perfused with ice-cold 0.15 M
NaCl and then isolated, washed well in ice-cold 0.15 M KCl,
blotted on a filter, and weighed as soon as possible. The
livers and sera obtained were stored at −80°C until use.
Assays of serum enzymes and components
Serum alanine aminotransferase (ALT) and aspartate
aminotransferase (AST) were assayed using a commercial
test kit of Iatrozyme TA-LQ (Dai-Iatron Co., Tokyo, Japan).
Serum γ-glutamyl transpeptidase (γ-GTP) was assayed using
a commercial test kit of γ-GTP C-Test Wako (Wako Pure
Chemical Industry Ltd., Osaka, Japan), respectively. These
enzyme activities are expressed as an international unit (IU/
l). Serum total bilirubin was assayed using commercial test
kits of Bilirubin BII-Test Wako (Wako Pure Chemical
Industry Ltd., Osaka, Japan), respectively. Serum ALT and
AST were used as indices of hepatic cell damage and serum
γ-GTP and total bilirubin as indices of biliary cell damage
and cholestasis.
Assays of hepatic components and enzymes
Livers were homogenized in 9 volumes of ice-old 0.15 M
KCl containing 1.0 mM EDTA using a glass homogenizer
with a Teflon pestle. This homogenate was used for hepatic
LPO and GSH assays. Hepatic LPO was assayed by the
method of Ohkawa et al. [18] using the thiobarbituric acid
reaction except that 1.0 mM EDTA was added to the
reaction medium. The concentration of hepatic LPO is
expressed as that of MDA equivalents. Hepatic GSH was
assayed by the method of Sedlak and Lindsay [19] using
Ellman’s reagent. The prepared liver homogenate was
sonicated on ice for 30 s × 2 times using a Handy Sonic model
UR-20P (Tomy Seiko Co., Tokyo, Japan). The sonicated
homogenate was centrifuged at 12,000 × g for 20 min and
the resultant supernatant was dialyzed against 100 volumes
of 0.05 M Tris-HCl buffer (pH 7.4) for 1 h using a micro-
dialysis device (Molecular weight cut-off = 3,500) (Bio-Tec
International Inc., Belleuve, WA). These treatments were
performed at 4°C. The dialyzed supernatant was used for
hepatic MPO, SOD, catalase, Se-GSH-Px, GSSG-R, and G-
6-PDH assays. MPO present in liver tissues was assayed as
follows: the dialyzed supernatant was incubated at 60°C
for 2 h to increase the recovery of MPO in liver tissues
according to the method of Schierwagen et al. [16]. MPO
activity in the heat-treated liver tissue sample was assessed
by measuring the H2O2-dependent oxidation of TMB
(dissolved in dimethylsulfoxide) at 37°C according to the
method of Suzuki et al. [20]. This TMB oxidation was
measured spectrophotometrically at 655 nm. One unit of this
enzyme activity is expressed as the amount of enzyme
causing a change in absorbance of 1.0 min−1 at 655 nm.
Hepatic SOD, catalase, Se-GSH-Px, GSSG-R, and G-6-
PDH were assayed by the methods of Oyanagui [21].
Bergmeyer [22], Hochstein and Utley [23], Lopez-Barea and
Lee [24], and Bergmeyer et al. [25], respectively. SOD
activity was determined at 37°C by the XO-NH2OH method
using purified bovine erythrocyte SOD (5000 units/mg
solid) as a standard. This enzyme activity is expressed as the
amount of the erythrocyte SOD showing activity equivalent
to the determined activity. Catalase activity was measured at
37°C by recording H2O2 decomposition at 240 nm. One unit
(U) of this activity is defined as the amount of enzyme
decomposing 1 µmol H2O2 as a substrate per min. Se-GSH-
Px activity was determined at 37°C by recording the
decrease in absorbance at 340 nm following the oxidation of
NADPH in the presence of H2O2, GSH, yeast GSSG-R, and
NaN3 as a catalase inhibitor. One unit (U) of this activity is
defined as the amount of enzyme oxidizing 1 µmol NADPH
per min. GSSG-R activity was measured at 37°C by
checking the oxidation of NADPH following the reduction
of GSSG to GSH at 340 nm. One unit (U) of this activity is
defined as the amount of enzyme oxidizing 1 µmol NADPH
per min. G-6-PDH activity was measured at 37°C by
checking the production of NADPH from NADP+ in the
presence of glucose-6-phosphate at 340 nm. One unit (U) of
this activity is defined as the amount of enzyme producing
1 µmol NADPH per min. Protein in liver tissue samples was
measured by the method of Lowry et al. [26] using bovine
serum albumin as a standard.
Histological examination
Liver samples were taken from the central part of the right
large lobe of ANIT-treated and untreated rats with and
without post-TJ-10 administration at 48 h after the treatment.
They were fixed with 10% formalin in phosphate buffered
saline for 24 h and then washed with tap water, dehydrated
in alcohols, and embedded in paraffin. Sections 6–7 µm
thick were mounted in glass slides. Staining with hematoxylin
and eosin (H-E) was performed in each slide and then histo-
logical examination was conducted under light microscopy.
Statistical analysis
All values obtained are expressed as the mean ± standard
deviation (SD). All data were statistically analyzed by
computerized statistical packages (StatView). Each mean
value is compared by one-way analysis of variance and
Fisher’s protected significant difference for multicomparison
as the post hoc test. The level of significance was set at
p<0.05.
Results
Serum ALT and AST activities, indices of hepatic cell
damage, in the ANIT-treated group significantly increasedTJ-10 and ANIT-Induced Liver Injury
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24 h after treatment with further their increases at 48 h when
compared with those in the control group (Fig. 2). TJ-10
administered orally to ANIT-treated rats at 24 h after the
treatment significantly reduced the enhanced increases in
serum ALT and AST activities at 48 h after the treatment at
its dose of 1.3 or 2.6 g/kg BW, but not 0.26 g/kg BW
(Fig. 2A and B). In the ANIT-treated group, serum γ-GTP
activity and total bilirubin concentration, which are indices
of biliary cell damage and cholestasis, significantly increased
24 h after treatment with further their increases at 48 h
when compared with those in the control group (Fig. 2 C
and D). The TJ-10 post-administered to ANIT-treated
rats significantly reduced the enhanced increases in serum γ-
GTP activity and bilirubin concentration at 48 h after the
treatment at its dose of 1.3 or 2.6 g/kg BW, but not 0.26 g/kg
BW (Fig. 2C and D). The increased serum ALT and AST
activities in the ANIT-treated group given TJ-10 (2.6 g/kg
BW) were near those in the ANIT-treated group found at
24 h after the treatment (Fig. 2A and B). The increased
serum γ-GTP activity in the ANIT-treated group given TJ-10
(1.3 or 2.6 g/kg BW) was almost equal to that in the ANIT-
treated group found at 24 h after treatment (Fig. 2C). The
same doses of TJ-10 given to ANIT-untreated did not affect
the serum ALT, AST, and γ-GTP activities and total bilirubin
concentration (Fig. 2).
The liver sections stained by H-E in ANIT-treated rats
post-administered with and without TJ-10 and untreated
control rats were examined for necrosis and the extent of
inflammation at 48 h after the treatment. Hepatocytes in the
untreated control group showed little histological changes
(Fig. 3A). Hepatocytes in the group treated with ANIT alone
presented necrotic and degenerative changes with severe
inflammatory cell infiltration (Fig. 3B). In contrast, hepato-
cytes in the ANIT-treated group post-administered with
TJ-10 (2.6 g/kg BW) presented clearly less necrotic and
degenerative changes and less inflammatory cell infiltration
(Fig. 3C).
Hepatic MPO activity in the ANIT-treated group was
significantly higher than that in the control group at 24 h
after treatment and the increase in hepatic MPO activity in
the ANIT-treated group was enhanced at 48 h (Fig. 4). TJ-10
(1.3 or 2.6 g/kg BW) post-administered to ANIT-treated rats
significantly reduced the enhanced increase in hepatic MPO
activity at 48 h after the treatment (Fig. 4). The hepatic MPO
activity in the ANIT-treated group given TJ-10 (1.3 or 2.6 g/
kg BW) was not significantly different from that in the
ANIT-treated group found at 24 h after the treatment. The
same doses of TJ-10 given to ANIT-untreated did not affect
the hepatic MPO activity (Fig. 4).
Significant increases in hepatic LPO and GSH contents
in the ANIT-treated group were found at 24 h after the
treatment when compared with those in the control group
and further increase in the hepatic LPO content occurred
Fig. 2.  Effect of orally post-Administered TJ-10 on serum
AST (A), ALT (B), and γ-GTP (C) activities and total
blirubin concentration (D) in rats treated with and with-
out ANIT. TJ-10 (0.26, 1.3 or 2.6 g/kg BW) was orally
administered to rats treated with and without ANIT
(75 mg/kg BW, i.p.) 24 h after the treatment. Rats not
given TJ-10 received vehicle at the same time point.
AST, ALT, γ-GTP, and total bilirubin in the serum of
each rat were assayed 24 or 48 h after ANIT treatment as
described in Materials and Methods. Each value is a
mean ± SD (n = 5 for ANIT-untreated rats with and
without TJ-10 administration; n = 8 for ANIT-treated
rats with and without TJ-10 administration). *Signifi-
cantly different from control rats without any treatment,
p<0.05.  #Significantly different from ANIT-treated rats
without TJ-10 administration, p<0.05.Y. Ohta et al.
J. Clin. Biochem. Nutr.
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with a slight decrease in the increased hepatic GSH content
at 48 h (Fig. 5). The post-administration of TJ-10 to ANIT-
treated rats at a dose of 1.3 or 2.6 g/kg BW, but not 0.26 g/kg
BW, significantly reduced the enhanced increase in hepatic
LPO content at 48 h after the treatment (Fig. 5A). TJ-10
post-administered at a dose of 2.6 g/kg BW significantly
attenuated the increased hepatic GSH content at 48 h after
ANIT treatment (Fig. 5B). The hepatic LPO content in the
ANIT-treated group given TJ-10 (1.3 or 2.6 g/kg BW) was
not significantly different from that in the ANIT-treated
group found at 24 h after the treatment (Fig. 5A). The
hepatic GSH content in the ANIT-treated group given TJ-10
(2.6 g/kg BW) was not significantly different from that in
the control group (Fig. 5B). The same doses of TJ-10 given
to ANIT-untreated rats did not affect the hepatic LPO and
GSH contents (Fig. 5).
Hepatic SOD and GSSG-R activities in the ANIT-treated
group were significantly lower than those in the control
group at 24 h after treatment, while there were no significant
differences in hepatic catalase, Se-GSHpx, and G-6-PDH
activities between the ANIT-treated and untreated control
rats at 24 h (Figs. 6 and 7). In the ANIT-treated group,
further decreases in hepatic SOD and GSSG-R activities
occurred with decreases in hepatic catalase, Se-GSHpx, and
G-6-PDH activities at 48 h after the treatment (Figs. 6 and
7). TJ-10 post-administered to ANIT-treated rats at a dose of
1.3 or 2.6 g/kg BW, but not 0.26 g/kg BW, significantly
reduced the enhanced decreases in hepatic SOD and GSSG-
R activities and the decreases in hepatic catalase, Se-GSHpx,
and G-6-PDH activities at 48 h after the treatment (Figs. 6
and 7). The hepatic SOD activity in the ANIT-treated group
given TJ-10 (1.3 or 2.6 g/kg BW) was not significantly
Fig. 3.  Histological figures of liver cells from control rats
and ANIT-treated rats with and without TJ-10 post-
administration. A, untreated control group: little histo-
logical change was observed; B, ANIT-treated group:
necrotic and degenerative changes with severe inflam-
matory cell infiltration were observed; C, ANIT-treated
group with oral administration ofTJ-10 (2.6 g/kg BW)
which was conducted 24 h after the treatment: dramatic
decreases in necrotic and degenerative changes and
inflammatory cell infiltration were seen. (H-E, original
magnification × 100).
Fig. 4.  Effects of orally post-administered TJ-10 on hepatic
MPO activity in rats treated with and without ANIT. Ex-
perimental condition and explanation are the same as de-
scribed in the legend for Fig. 2 except that hepatic MPO
was assayed as described in Materials and Methods.TJ-10 and ANIT-Induced Liver Injury
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different from that in the ANIT-treated group found at 24 h
after the treatment (Fig. 6A) In addition, the ANIT-treated
group given TJ-10 (2.6 g/kg BW) had as much hepatic G-6-
PDH activity as the control group (Fig. 7C). The same doses
of TJ-10 given to ANIT-untreated rats did not affect the
hepatic SOD, GSSG-R, catalase, and Se-GSHpx activities
but the hepatic G-6-PDH activity in ANIT-untreated group
given TJ-10 at a dose of 2.6 g/kg BW, but not 0.26 or 1.3 g/
kg BW, was significantly higher than that in untreated con-
trol rats (Figs. 6 and 7).
Discussion
In the present study, rats treated with ANIT exhibited
apparent liver injury with cholestasis at 24 h after treatment
and progressed liver injury at 48 h, judging from the serum
levels of ALT, AST, γ-GTP, and bilirubin, as shown in our
previous reports [6–9, 12]. When TJ-10 (0.26, 1.3 or 2.6 g/
kg BW) was orally administered to the ANIT-treated rats
at 24 h after the treatment at which time liver injury had
appeared, progressive liver injury associated with liver cell
damage and biliary cell damage with cholestasis was signif-
icantly attenuated at its does of 1.3 or 2.6 g/kg BW, judging
from the serum levels of hepatobiliary markers, as shown in
our previous report [12]. In addition, the post-administration
of TJ-10 (2.6 g/kg BW) prevented the progression of ANIT-
induced liver injury almost completely. This preventive effect
of TJ-10 on ANIT-induced liver injury was confirmed by
histological observation. Thus, it has been shown clearly
that orally administered TJ-10 exerts a therapeutic effect on
ANIT-induced liver injury with cholestasis in rats.
It is generally accepted that infiltrating neutrophils play
an important role in the development of ANIT-induced liver
injury [2–5]. In the present study, an enhanced increase in
the hepatic activity of MPO, an index of tissue neutrophil
infiltration [15–17], occurred at a progressed stage of ANIT-
induced liver injury, as shown previously [6–9]. TJ-10 (1.3
or 2.6 g/kg BW) administered orally to ANIT-treated rats
Fig. 5.  Effect of orally post-administered TJ-10 on hepatic LPO
(A) and GSH (B) contents in rats treated with and with-
out ANIT. Experimental condition and explanation are
the same as described in the legend for Fig. 2 except that
hepatic LPO and GSH were assayed as described in Ma-
terials and Methods.
Fig. 6.  Effect of orally post-administered TJ-10 on hepatic SOD
(A) and catalase (B) activities in rats treated with and
without ANIT. Experimental condition and explanation
are the same as described in the legend for Fig. 2 except
that hepatic SOD and catalse were assayed as described
in Materials and Methods.Y. Ohta et al.
J. Clin. Biochem. Nutr.
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after the appearance of liver injury significantly reduced the
enhanced increase in hepatic MPO activity found at a pro-
gressed stage of liver injury. In addition, both doses of the
herbal medicine attenuated the enhanced increase in hepatic
MPO activity completely. These results suggest that orally
administered TJ-10 exerts a therapeutic effect on ANIT-
induced liver injury in rats by inhibiting enhanced neutrophil
infiltration into the liver tissue. TJ-10 is known to protect
against gut ischemia/reperfusion-induced liver injury in rats
by NO-mediated inhibition of neutrophil infiltration into the
liver [11]. Accordingly, there may be a possibility that post-
administered TJ-10 inhibits enhanced neutrophil infiltration
into the liver of ANIT-treated rats by the NO-mediated
mechanism. This possibility should be clarified in the future
research.
Our previous reports suggested that lipid peroxdation
might be closely associated with the development of ANIT-
induced liver injury in rats [6,  7,  9]. TJ-10 is known to
inhibit lipid peroxidation in vitro [13] and to scavenge ROS
such as O2˙− and ˙OH, which are generated by the reaction
between O2˙− and H2O2 (Haber-Weiss reaction) or by the
reaction between H2O2 and tradition metals (Fenton
reaction), in vitro [14]. Gao et al. [27] have reported that
baicalin, baicalein, and wogonin in Scuttellariae Radix, one
of the components of Saikokeishito, possess an activity
to scavenge ˙OH and alkyl radical in vitro and exert an
inhibitory action on lipid peroxidation induced in vitro in
different extents. Yokozawa et al. [28] have shown that
Saikokeishito and its constituent herbs such as Bupleuri
Radix,  Cinnamoni Cortex,  Ginseng Radix,  Glycyrrhizae
Radix, Paeoniae Radix, Pinelliae Tuber, Scuttellariae Radix,
and Zingiberis Rhizoma inhibit lipid peroxidation induced
by H2O2 in rat liver homogenates and that Cinnamoni
Cortex,  Ginseng Radix,  Glycyrrhizae Radix,  Paeoniae
Radix, Pinelliae Tuber, and Scuttellariae Radix inhibit lipid
peroxidation induced by H2O2 + FeSO4 (the so-called Fenton
reaction), i.e., ˙OH, in rat liver homogenates. In the present
study, an enhanced increase in hepatic LPO content occurred
at a progressed stage of ANIT-induced liver injury, as shown
previously [6, 7, 9]. TJ-10 (1.3 or 2.6 g/kg BW) administered
orally to ANIT-treated rats after the appearance of ANIT-
induced induced liver injury was found to attenuate the
enhanced increase in hepatic LPO content observed at a
progressed stage of liver injury significantly. In addition,
both doses of the herbal medicine attenuated the enhanced
increase in hepatic LPO content completely. The same doses
of TJ-10 did not affect hepatic LPO content in ANIT-
untreated rats.
It has been shown that neutrophils mediate lipid peroxidation
through the production of superoxide radical via activated
NADPH oxidase in the cells [29]. It has also been shown that
MPO mediates lipid peroxidation in the presence of H2O2
with halide ions [30]. We have suggested that neutrophil-
derived ROS-related lipid peroxidation might be associated
with the formation and progression of ANIT-induced liver
injury in rats [6, 7, 9]. Accordingly, these findings suggest
that orally administered TJ-10 exerts a therapeutic effect on
ANIT-induced liver injury in rats by inhibiting an enhance-
ment of hepatic lipid peroxidation meditated by infiltrated
neutrophils in the liver tissue.
In the present study, the increased hepatic GSH content
Fig. 7.  Effect of orally post-administered TJ-10 on hepatic Se-
GSHpx (A), GSSG-R (B), and G-6-PDH (C) activities in
rats treated with and without ANIT. Experimental condi-
tion and explanation are the same as described in the leg-
end for Fig. 1 except that hepatic Se-GSHpx, GSSG-R,
and G-6-PDH were assayed as described in Materials
and Methods.TJ-10 and ANIT-Induced Liver Injury
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found at an early stage of liver injury was slightly reduced at
a progressed stage of injury in rats treated with ANIT, as
shown previously [7,  9]. TJ-10 administered to ANIT-
treated rats at an early stage of liver injury reduced the
increase in hepatic GSH concentration found at a progressed
stage of injury at a dose of 2.6 g/kg BW. Dahm and Roth
[31] reported that depletion of hepatic GSH by pretreatment
with a glutathione synthesis inhibitor, buthionine sulfoximine,
or a glutathione depletor, diethylmaleate or phorone, pro-
tected against ANIT-induced acute liver injury in rats, and
suggested that GSH played a causal or permissive role in the
ANIT-induced liver injury. It has been suggested that ANIT
secreted as a reversible GSH conjugate into bile damages
bile duct epithelial cells and induces cholestasis in rats
treated with the hepatotoxin [32–34]. Thus, the highest dose
of TJ-10 administered after the appearance of liver injury
may reduce the cytotoxicity of ANIT secreted as a GSH
conjugate into bile against bile duct epithelial cells in rats
treated with the hepatotoxin.
Our previous reports have shown that, in rats treated
once with ANIT, hepatic SOD and GSSG-R activities
decrease with injury formation and progression, while
catalase, and Se-GSHpx activities decrease with liver injury
progression [7–9]. In the present study, not only hepatic
SOD, catalase, Se-GSHpx, and GSSG-R activities but also
hepatic G-6-PDH activity was found to decrease at a
progressed stage of ANIT-induced acute liver injury in rats.
Oral administration of TJ-10 (1.3 or 2.6 g/kg BW) to ANIT-
treated rats at an early stage of liver injury significantly
attenuated the decreases in hepatic SOD, catalase, Se-
GSHpx, GSSG-R, and G-6-PDH activities found at a pro-
gressed stage of liver injury. In addition, TJ-10 administered
to ANIT-treated rats at a dose of 1.3 or 2.6 g/kg BW
attenuated the enhanced decrease in hepatic SOD activity
completely. TJ-10 administered to ANIT-treated rats at a
dose of 2.6 g/kg BW attenuated the decreased hepatic
G-6-PDH activity completely. The same doses of TJ-10
administered to ANIT-untreated rats did not affect hepatic
SOD, catalase, Se-GSHpx, and GSSG-R activities but the
herbal medicine administered at a dose 2.6 g/kg BW caused
a significant increase in hepatic G-6-PDH activity. However,
the mechanism for the action of TJ-10 to increase hepatic G-
6-PDH activity in ANIT-untreated rats is unknown at
present. These results suggest that orally administered TJ-10
exerts a therapeutic effect on ANIT-induced liver injury in
rats by attenuating an enhanced disruption of antioxidant
defense systems in the liver tissue.
The mechanism by which hepatic SOD, catalase, Se-
GSHpx, GSSG-R, and G-6-PDH activities are reduced with
liver injury development in rats treated with ANIT has not
been elucidated. However, Cu,Zn-SOD is inactivated in
vitro by H2O2 [35]. Catalase and G-6-PDH are inactivated
in vitro by O2˙− [ 36,  37]. Se-GSHpx and GSSG-R are
inactivated in vitro by ˙OH [38]. Cu,Zn-SOD, catalase, and
Se-GSHpx are inactivated by hypochlorous acid in vitro
[39]. Cu,Zn-SOD is inactivated by the MPO-H2O2-Cl−
system in vitro [40]. We have shown that the activity of
Cu,Zn-SOD, which is localized in the cytosol of cells, but
not the activity of Mn-SOD, which is localized in the
mitochondira of cells, in the liver of ANIT-treated rats
decreases with liver injury development [8, 9]. As described
above, ANIT-treated rats showed an increase in hepatic
MPO activity with decreases in hepatic SOD, catalase, and
Se-GSHpx activities at a progressed stage of liver injury and
these changes were attenuated by post-administered TJ-10.
Nuetrophils generate O2˙− and H2O2 via NADPH oxidase and
hypochlorous acid via MPO in the presence of H2O2 and
Cl−. It is known that TJ-10 scavenges O2˙− and ˙OH in vitro
[14]. It is also known that Scuttellariae Radix, one of the
constituents of Saikokeishito, scavenges ROS such as O2˙−
and ˙OH in vitro [41]. Therefore, it seems likely that the en-
hanced decreases in hepatic SOD and GSSG-R activities and
the decrease in hepatic catalase, Se-GSHpx, and G-6-PDH
activities found at a progressed stage of liver injury in
ANIT-treated rats are due to ROS derived from neutrophils
accumulating in the tissue.
In conclusion, the results of the present study indicate that
orally administered TJ-10 exerts a therapeutic effect on
ANIT-induced liver injury with cholestasis in rats, possibly
through attenuation of enhanced neutrophil infiltration and
oxidative stress associated with disrupted antioxidant defense
systems in the liver tissue, by its anti-inflammatory and anti-
oxidant actions.
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